aspirin has been researched along with Embolism, Fat in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Embolism, Fat: Blocking of a blood vessel by fat deposits in the circulation. It is often seen after fractures of large bones or after administration of CORTICOSTEROIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results of treatment of the fat embolism syndrome should improve if there is a realization that even relatively uncomplicated fractures of the extremities cause significant metabolic, platelet, coagulation and pulmonary changes." | 2.36 | Fat embolism syndrome: traumatic coagulopathy with respiratory distress. ( Shier, MR; Wilson, RF, 1980) |
| "After the induction of fat embolism, intravenous aspirin was administered at a dose of 150 mg/hr for 2 hrs (aspirin-treated group)." | 1.30 | Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. ( Gullichsen, E; Kuttila, K; Mucha, I; Nelimarkka, O; Niinikoski, J; Rautanen, M; Riutta, A, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shier, MR | 2 |
| Wilson, RF | 2 |
| Rautanen, M | 1 |
| Gullichsen, E | 1 |
| Riutta, A | 1 |
| Kuttila, K | 1 |
| Mucha, I | 1 |
| Nelimarkka, O | 1 |
| Niinikoski, J | 1 |
| James, RE | 1 |
| Riddle, J | 1 |
| Mammen, EF | 1 |
| Pedersen, HE | 1 |
| Schimpf, K | 1 |
| Piechotta, A | 1 |
| Ehm, OF | 1 |
| Fritsch, H | 1 |
1 review available for aspirin and Embolism, Fat
| Article | Year |
|---|---|
Fat embolism syndrome: traumatic coagulopathy with respiratory distress.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Coagulation Disorders; Blood Platelets; Cholesterol; Embolis | 1980 |
1 trial available for aspirin and Embolism, Fat
| Article | Year |
|---|---|
Fat embolism prophylaxis: a study of four treatment modalities.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Carbon Dioxide; Dextrans; Embolism, Fat; Factor V; Fibr | 1977 |
2 other studies available for aspirin and Embolism, Fat
| Article | Year |
|---|---|
Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Cyclooxygenase Inhibitors; Embolism, Fat; Epoprosten | 1997 |
[Experimental decompression sickness in rabbits. Coagulation changes and therapeutic influencing].
Topics: Animals; Antifibrinolytic Agents; Aprotinin; Aspirin; Blood Cell Count; Blood Coagulation Disorders; | 1971 |